TS

Trilochan Singh Gill

Active Director Designated Partner DIN 09409378
DIN 09409378 First appointment Nov 2021 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Trilochan Singh Gill

Data last updated:

Trilochan Singh Gill is a Designated Partner at Mcgill Healthcare & Pharmaceuticals Llp (since 2021). The company operates in Healthcare.

DIN 09409378
Primary Designation Designated Partner
Industry Healthcare
First Appointment 23 Nov 2021
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner23 Nov 20212021Active

Board colleagues of Trilochan Singh Gill

NameDINCompanyDesignation
Gurjeet Singh Gill09409379Mcgill Healthcare & Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Mcgill Healthcare & Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Trilochan Singh Gill

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Trilochan Singh Gill

Trilochan Singh Gill currently holds 1 directorship: Mcgill Healthcare & Pharmaceuticals Llp (Designated Partner, since 23 Nov 2021).

Trilochan Singh Gill was first appointed on 23 Nov 2021 as Designated Partner at Mcgill Healthcare & Pharmaceuticals Llp.

The current boards of Trilochan Singh Gill's companies include Gurjeet Singh Gill (Mcgill Healthcare & Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available